E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/10/2014 in the Prospect News PIPE Daily.

Arch Therapeutics settles $2.85 million private placement of its units

Deal sells 11.4 million units of one common share and three warrants

By Devika Patel

Knoxville, Tenn., Feb. 10 - Arch Therapeutics Inc. settled a $2.85 million private placement of units on Feb. 4, according to an 8-K filed Monday with the Securities and Exchange Commission. The deal priced on Jan. 30.

The company sold 11.4 million units of one common share and three warrants at $0.25 per unit.

The life science company is based in Dublin, Ireland.

Issuer:Arch Therapeutics Inc.
Issue:Units of one common share and three warrants
Amount:$2.85 million
Units:11.4 million
Price:$0.25
Warrants:Three warrants per unit
Pricing date:Jan. 30
Settlement date:Feb. 4
Stock symbol:OTCBB: ARTH
Stock price:$0.39 at close Jan. 29

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.